Peter Lynch fit · Growth at a reasonable price (GARP)
Is Arrowhead Pharmaceuticals, Inc. (ARWR) a Peter Lynch Stock?
Strong GARP candidate - growth at a reasonable price.
75/100
BAction Lynch probable
4/6 critères validés
Les critères de Peter Lynch, appliqués à ARWR
PEG ≤ 1.0
clé-
EPS CAGR ≥ 15%
clé-
Revenue CAGR ≥ 10%
56.5%
Net margin > 0
18.5%
Comment ARWR se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$10.56B
PER (TTM)
-
ROIC (TTM)
-10.98%
Marge brute
98.98%
Autres analyses Peter Lynch
Questions fréquentes
What is ARWR's Peter Lynch fit score?
ARWR scores 75/100 on our Peter Lynch fit engine - grade B. Strong GARP candidate - growth at a reasonable price.
Does Peter Lynch actually own ARWR?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends ARWR.
How often is this score updated?
ARWR's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Peter Lynch possède ou recommande ARWR personnellement.